Beam Therapeutics Inc. Common Stock (BEAM) Sentiment
30-day SentiSense Score 4.1 · Neutral · ▲ warming · as of 2026-09-07
BEAM sentiment is neutral (30-day SentiSense Score 4) and strengthening from a month ago; there is no reading for today yet. Attention averages ~4 mentions/day (2 today).
- Sentiment (30-day)
- Neutral
- SentiSense Score (30-day avg)
- 4.1
- Mentions / day (30-day avg)
- 4 (2 today)
Where the conversation is happening
- News
- Bullish · 42% of mentions
- X
- Bullish · 36% of mentions
- Neutral · 22% of mentions
Related tickers
What's driving it
- Prime Medicine Wins Arbitration Over AATD Therapy PM647 (+0.6)
- FDA Clears Gene Therapy Trial for Phenylketonuria (PKU) (+0.78)
- Beam Therapeutics Advances Phase 1/2 Trial for AAT Deficiency with Gene-Editing Therapy (+1)
Live SentiSense Score, sentiment history, and per-source breakdown for Beam Therapeutics Inc. Common Stock on SentiSense.
See how BEAM's sector compares in the market sentiment heatmap